HomeKROS • NASDAQ
add
Keros Therapeutics Inc
Previous close
$54.19
Day range
$53.69 - $58.45
Year range
$27.02 - $73.00
Market cap
2.09B USD
Avg Volume
339.44K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 143.00K | — |
Operating expense | 9.10M | 28.37% |
Net income | -40.24M | -35.42% |
Net profit margin | -28.14K | — |
Earnings per share | -1.34 | -22.94% |
EBITDA | -46.21M | -45.16% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 331.15M | 18.67% |
Total assets | 370.02M | 20.62% |
Total liabilities | 37.81M | 28.80% |
Total equity | 332.21M | — |
Shares outstanding | 35.98M | — |
Price to book | 5.20 | — |
Return on assets | -33.36% | — |
Return on capital | -35.36% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -40.24M | -35.42% |
Cash from operations | -25.46M | -18.73% |
Cash from investing | -541.00K | -54.13% |
Cash from financing | 69.25M | 12.76% |
Net change in cash | 43.25M | 9.17% |
Free cash flow | -14.33M | -33.92% |
About
Founded
2015
Headquarters
Website
Employees
136